Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Nat Commun. 2025 Jan 15;16(1):704. doi: 10.1038/s41467-025-56170-9.
No abstract available

Publication types

  • Published Erratum